Compliant Cloud Computing: Applications and Software as a Service

The life sciences industry is increasingly adopting the use of computerised and automated test tools in the support of software and applications validation. This webcast will discuss how such tools can be used in a compliant manner, how to comply with the requirements of the EU annex 11 and the return on investment provided by the use of such tools.

Testing good practices in the life sciences industry have evolved in the seven years since the publication of the original GAMP “Testing of GxP Systems” good practice guide. In this webcast our contributors to the second edition of the guide will discuss what has changed in intervening period and what is different in the new version of the guide.

In many cases Regulated Companies struggle to address regulatory enforcement actions while relying on general IT service providers or hired contractors. Compliance as a Service is increasingly seen as a more sustainable and successful model when compared to traditional IS Compliance outsourcing models which are failing to deliver the right balance between cost and compliance.

Advances in technology mean that an increasingly mobile workforce can continue to interact with GxP significant applications while on the move but what are the implications for regulatory compliance? Hear our experts discuss how to address issues associated with uncontrolled networks and an increasing array of mobile computing platforms.

Life Sciences organizations are now starting to realize that Software as a Service isn’t the answer to everything – but that Infrastructure as a Service delivers the promise of Cloud but with fewer compliance risks. In this webcast our experts will look at the growing use of pre-engineered and pre-qualified Cloud solutions that can be deployed On-Premise, off-Premise and managed remotely.

Cloud computing represents the greatest paradigm shift in computing since the turn of the century, but how is the regulated life sciences industry adapting to cloud computing. Business & Decision Life Sciences experts discuss the current state of the Compliant Cloud Computing market.

In this final, short question and answer web session (including questions submitted by participants), David Stokes will be looking at how increasing regulation in emerging economies neccesitated a new look at retrospective validation in his new book "Validating Enterprise Systems: A Practical Guide"

In the third of four short question and answer web sessions (including questions submitted by participants), David Stokes will be discussing how the publication of "Validating Enterprise Systems: A Practical Guide" addresses the hot topic of Enterprise Applications in the Cloud

In this second, short question and answer web session (including questions submitted by participants), David Stokes will describe how ICH Q9 and ISO 14971 led to a more practical approach to Risk Management, described in his new book "Validating Enterprise Systems: A Practical Guide"

In this short question and answer web session (including questions submitted by participants), David Stokes will be discussing recent changes in predicate rules, the broader integration of the Life Sciences Enterprise, changes in technology and how it drove the publication of "Validating Enterprise Systems: A Practical Guide"

Discover how you can break through doubts about perceived benefits, costs, risks, and time for implementing a new ERP system. Business & Decision can show you a finely tuned approach to ROI analysis: Future-facing, believable, and backed with the proof decision makers are looking for.

Register now—and make sure to click the link shown above to download our complimentary overview of ROI analysis for ERP. For the webcast, we’ll explore the language of ROI analysis and how you literally can turn problems with your current system into a new solution:

• Investigating and quantifying benefits that are meaningful to your organization
• Redefining issues such as risks, downtime, customization, and support
• Applying a structured approach that yields believable costs and payback period
• Presenting a long-term roadmap for a proposed solution

You CAN build a case that won’t be denied. We look forward to your joining!

We are holding a 1 hour webinar to discuss our key takeaways from Inforum and what they may mean for the Baan community. We will break it down in such a way that you get the basics of what was presented and come away with a synopsis of the key points delivered. We are always willing to go into more detail at a later date if you have an interest in a specific topic.

The agenda will be as follows:

• The Inforum Experience
• Infor10 ERP Enterprise (LN) Update
• What is Infor ION?
• Q&A

Please join us for this 1 hour informative webinar and you will leave thinking that you were in the seat next to us at Inforum!!

An increasing number of health sciences companies are using social networking and social CRM to reach out to diverse stake-holder groups such as health care professionals, collaboration partners, patients and consumers. While social networking provides an opportunity for engaging stakeholders in a two-way dialogue, regulations nevertheless constrain the content of those conversations. While pharmaceutical companies are starting to leverage social media and benefit from greater interaction with their stakeholders, the medical devices sector is seen as lagging behind.

Reason #10: Unless you have money to burn, you'll love knowing that Infor10* Integrated Supply Chain helps contain costs.

Reason #9: Customers need love too, which is why Infor10 includes some seriously improved CRM.

Reason #8: Manufacturing is getting harder, not easier. You need more from ERP, not less.

Reason #7: Infor10 ION Makes Sure Your Applications and ERP Are on Speaking Terms

On March 20th, view our complimentary "Top 10 Reasons" webinar during which B&D Infor expert Chris Andria will lay out all 10 reasons, and:

• Show you how various Infor versions compare in features, functionality and benefits
• Share common upgrade criteria applied by successful upgraders
• Provide business case scenarios to help Decision Makers understand why an upgrade is worth the company’s time and money

We'll also answer questions and, in general, make sure you have the facts you need to consider whether or not Infor10 is right for you.

* Formerly ERP LN

ERP vendors promise life sciences organizations a world of improvements from optimization to compliance, but the reality is in many cases implementations run over schedule, over budget and aren’t even close to being compliant. To prevent this from happening to you, listen as Business & Decision ERP experts share decades of experience and secrets for a successful (and compliant) ERP project. You’ll learn how to align all phases of an ERP project -- planning, implementation, project management and validation – as well as how to clearly define your project team roles, responsibilities and resources.

This is the fifth in a series of five live webcasts by Business & Decision life sciences experts designed to help you optimize compliant business processes, reduce operational costs and improve margins.

Improving profitability in the medical devices sector is dependent upon effective multi-channel marketing, driving sales through effective relationship management, retaining and growing market share through enhanced customer satisfaction, delivering better therapeutic outcomes through effective patient management and achieving efficient regulatory compliance in all customer and patient interactions. In this webcast Business & Decision's Life Sciences and CRM experts will show how this can be achieved through the implementation of an effective relationship management strategy, enabled by a suitable relationship management (xRM) platform.

Many industrial manufacturers, having replaced their business management solutions approximately 10 or more years ago, are currently burdened with legacy or obsolescent systems.
What are the issues they face by continuing to utilize their current, outdated systems? What are the risks of moving to a brand new system? Should they upgrade to the latest versions offered by their current vendor, oftentimes requiring a re-implementation? Does it make sense to do a complete re-platform and introduce a new vendor? This webcast will expose the issues of the status quo and highlight the considerations involved in making a change.